Local Institution

Cambridge, Ontario N1R 7R1

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndromes, Atrial Fibrillation, Atrial Flutter, Deep Vein Thrombosis, Paroxysmal Atrial Fibrillation, Pulmonary Embolism, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation — Stopped early
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery — Completed
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed